Intelligent Bio Solutions (INBS) announced that Princebuild has adopted INBS’ Intelligent Fingerprinting Drug Screening System, IFDSS. Princebuild has made a strategic decision to move from saliva testing to fingerprint drug screening in order to implement a more streamlined, in-house solution that prioritizes efficiency, accuracy, and respect for employee privacy. “By adopting Intelligent Bio Solutions fingerprint sweat-based system, we have transformed our approach to workplace testing,” said Cheryl Browne, Human Resources Support Manager at Princebuild. “We wanted a method that ensured safety in our workplace without feeling like we were policing our employees’ lifestyles. The simplicity and efficiency of this solution aligns with our company values.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Submits FDA Premarket Notification
- Intelligent Bio Solutions announces 510k submission to FDA on FDSS
- Intelligent Bio Solutions Releases Business Operations Presentation
- Intelligent Bio Solutions Advances Fingerprint Drug Testing
- Intelligent Bio completes method comparison study of Fingerpriinting system